MedTrace Logo

Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up

NCT01412554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2019-10-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to identify risk factors for insulin resistance and to investigate the influence of insulin sensitivity on development of cardiovascular risk markers like blood pressure, heart rate, body build (weight, BMI, waist-hip ratio, skinfold thickness), reduced insulin sensitivity, diabetes mellitus, dyslipidaemia, and sympathoadrenal activity or manifest cardiovascular disease among young men during 10-20 years.

Conditions

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Sverre E Kjeldsen, PhD · Oslo Univeristy Hospital

Eligibility

Min Age
30 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-03-31
Completion
2015-03-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01412554 on ClinicalTrials.gov